CNS Pharmaceuticals, Inc.
NASDAQ:CNSP
0.1131 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 0.549 | 10.055 | 5.005 | 14.039 | 7.241 | 0.283 | 0.111 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.549 | 10.055 | 5.005 | 14.039 | 7.241 | 0.283 | 0.111 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.84 | 2.509 | 2.473 | 1.456 | 0.653 | 0.033 | 0.052 |
Total Current Assets
| 1.388 | 12.565 | 7.477 | 15.496 | 7.894 | 0.588 | 0.162 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0.005 | 0.006 | 0.016 | 0.023 | 0.018 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.308 | 0.483 | 1.264 | 0.334 | -0 | 0.095 | 0 |
Total Non-Current Assets
| 0.313 | 0.488 | 1.28 | 0.358 | 0.018 | 0.095 | 0 |
Total Assets
| 1.701 | 13.053 | 8.757 | 15.853 | 7.912 | 0.683 | 0.162 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 5.832 | 3.682 | 1.523 | 0.946 | 0.289 | 0.129 | 0.057 |
Short Term Debt
| 0.301 | 0.41 | 0.388 | 0.439 | 0 | 0.317 | 0.122 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| -5.832 | 0 | 0 | 0 | 0 | 0.024 | 0 |
Other Current Liabilities
| 5.832 | 0.828 | 0.225 | 0.52 | 0.022 | 0.763 | 0.041 |
Total Current Liabilities
| 6.133 | 4.92 | 2.136 | 1.905 | 0.311 | 1.233 | 0.221 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 4.092 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 4.092 | 0 | 0 | 0 | 0.446 | 0.179 |
Total Liabilities
| 6.133 | 4.92 | 2.136 | 1.905 | 0.311 | 1.233 | 0.221 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.006 | 0.002 | 0.028 | 0.024 | 0.016 | 0.013 | 0.01 |
Retained Earnings
| -69.567 | -50.716 | -34.983 | -20.946 | -11.488 | -7.611 | -0.219 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -0 | -0 | 0 | 0 |
Other Total Stockholders Equity
| 65.129 | 58.847 | 41.577 | 34.87 | 19.073 | 7.049 | 0.151 |
Total Shareholders Equity
| -4.432 | 8.133 | 6.622 | 13.948 | 7.601 | -0.549 | -0.059 |
Total Equity
| -4.432 | 8.133 | 6.622 | 13.948 | 7.601 | -0.549 | -0.059 |
Total Liabilities & Shareholders Equity
| 1.701 | 13.053 | 8.757 | 15.853 | 7.912 | 0.683 | 0.162 |